BOYDSense
BOYDSense - Health monitoring made simple powered by breath.
| USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
BOYDSense, an award-winning startup with R&D in France and the U.S., is a pioneer in the development of non-invasive breath analysis solutions for the risk stratification, screening, monitoring and detection of different biomarkers.
BOYDSense is currently developing its first product, a miniaturized breath analyzer for monitoring glucose concentration in pre-diabetics and type 2 diabetics. The device detects the type and concentration of volatile organic compounds in breath. The solution is pain-free, affordable, and produces significantly less waste compared to existing fingerstick blood glucose or continuous glucose monitors.
Keywords: Healthcare, Medical Devices, Breath Analysis, Chronic Conditions, Diagnostics, Disease screening, Diabetes Monitoring Device, Health Information, Health Monitoring Device.